M
Exchange
—
Entity type
operating
Fiscal year end
Dec 31
Headquarters
DE
Recent Filings
- SC 13D94.6 KBMAP Pharmaceuticals, Inc.Jan 29, 5:03 PM ET·0001193125-13-028288
- 8-K23.5 KBMAP Pharmaceuticals, Inc.May 24, 2:01 PM ET·0001193125-11-148956
- 8-K22.8 KBMAP Pharmaceuticals, Inc.Oct 4, 11:53 AM ET·0001193125-10-222702
- 8-K54.9 KBMAP Pharmaceuticals, Inc.May 4, 7:46 AM ET·0001193125-10-105424
- 8-K28.2 KBMAP Pharmaceuticals, Inc.Jan 11, 7:45 AM ET·0001193125-10-003945
- 8-K67.6 KBMAP Pharmaceuticals, Inc.Aug 3, 8:06 AM ET·0001193125-09-161571
- 10-Q605.1 KBMAP Pharmaceuticals, Inc.Aug 3, 8:00 AM ET·0001193125-09-161559
- SC 13G/A99.1 KBMAP Pharmaceuticals, Inc.Feb 2, 3:59 PM ET·0001193125-09-016365
- 415.8 KBMAP Pharmaceuticals, Inc.Jul 8, 1:24 PM ET·0001181431-08-042501
- 421.4 KBMAP Pharmaceuticals, Inc.Jul 7, 5:10 PM ET·0001181431-08-042380
Insiders
10- ARMER THOMAS ADirector, Chief Scientific Officer
- Borland ScottSVP, Neurology Franchise
- CHAI CHRISTOPHER YSVP, Chief Financial Officer
- Freund John GordonDirector, 10% Owner
- Friedman Charlene ASVP, Gen Counsel & Sec
- GIANAKAKOS ANASTASIOSSVP, Cor & Business Dev
- HENWOOD GERALDINEDirector
- KELLERMAN DONALD JSVP,Clinical Dev & Med Affairs
- KELLEY BERNARD JDirector
- MCPHERRON MATTHEW VDirector, 10% Owner
Tickers
No tickers on record
Addresses
business
2400 BAYSHORE PARKWAY, SUITE 200
MOUNTAIN VIEW, CA, 94043
mailing
2400 BAYSHORE PARKWAY, SUITE 200
MOUNTAIN VIEW, CA, 94043